Trials / Completed
CompletedNCT02435238
AWARE - Chronic Urticaria
AWARE: A World-wide Antihistamine-Refractory Chronic Urticaria Patient Evaluation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 180 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Non interventional study collecting patient reported outcomes. The study aims to assess the disease burden of chronic urticaria patients and to record the therapies used in daily clinical practice in the UK and the impact they have on the quality of life and work productivity of individual patients.
Conditions
Timeline
- Start date
- 2014-09-03
- Primary completion
- 2017-09-27
- Completion
- 2017-09-27
- First posted
- 2015-05-06
- Last updated
- 2018-02-15
Locations
21 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02435238. Inclusion in this directory is not an endorsement.